Pompholyx after IV immunoglobulin therapy for neurologic disease.
Ikeda
K
K
Iwasaki
Y
Y
Ichikawa
Y
Y
Kinoshita
M
M
D000368:Aged; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D011146:Eczema, Dyshidrotic / Q000209:etiology*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000097:blood; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000628:therapy*; D012008:Recurrence
D007074:Immunoglobulin G